Last checked at 
Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP19.5 million for 2022, up 40% from GBP13.9 million in 2021. Pretax profit is GBP564,000, up from GBP462,000, as operating profit increases to GBP575,000 from GBP550,000 a year earlier. Administrative expenses increase to GBP16.3 million from GBP11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to GBP3.6 million, up from GBP2.3 million. Order book stands at GBP16.9 million at year-end, compared to GBP1.8 million a year earlier.
Chief Executive Officer Peter Keeling says: "We have delivered another year of significant financial and operational progress, increasing revenue materially ahead of initial expectations, driven by the demand from our pharma customers for our expanded offering of platform solutions. As Diaceutics continues to expand its platform offering and execute against its strategic goals, we look to the future with confidence as we work to become the primary partner for pharma or biotechs launching a precision medicine."
Current stock price: 103.40 pence each, up 2.9% on Monday afternoon in London
12-month change: down 6.9%
By Xindi Wei, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
